GSK to produce new world drug in Poznań plant

Over the next few years, pharmaceutical company GlaxoSmithKline Pharma ceuticals intends to invest zł. 180 million in Poland. Of this amount, zł. 63 million will be spent on launching a new medicine in the GSK Pharma ceuticals subsidiary in Poznań. According to company president Mark Lo ughran, launching the production of the drug will result in 40-60 new jobs. Currently, the number of employees stands at 720. "The new medicine is targeted at the entire world market, which will considerably increase the share of export in our sales," said Loughran. He added that increasing output will make the Poznań plant the sixth largest GSK Pharmaceuticals' subsidiary in Europe. He refused to disclose the name of the drug. (Puls Biznesu, p. 13) A.Z